Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.57 billion. The enterprise value is $1.92 billion.
| Market Cap | 2.57B |
| Enterprise Value | 1.92B |
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 122.39 million shares outstanding. The number of shares has increased by 6.49% in one year.
| Current Share Class | 122.39M |
| Shares Outstanding | 122.39M |
| Shares Change (YoY) | +6.49% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 84.32% |
| Float | 114.77M |
Valuation Ratios
The trailing PE ratio is 12.72 and the forward PE ratio is 15.72. CPRX's PEG ratio is 1.37.
| PE Ratio | 12.72 |
| Forward PE | 15.72 |
| PS Ratio | 4.54 |
| Forward PS | 4.45 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | 9.34 |
| P/OCF Ratio | 9.33 |
| PEG Ratio | 1.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.82, with an EV/FCF ratio of 6.98.
| EV / Earnings | 9.19 |
| EV / Sales | 3.43 |
| EV / EBITDA | 6.82 |
| EV / EBIT | 7.87 |
| EV / FCF | 6.98 |
Financial Position
The company has a current ratio of 6.71, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.71 |
| Quick Ratio | 6.36 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 28.49% and return on invested capital (ROIC) is 20.68%.
| Return on Equity (ROE) | 28.49% |
| Return on Assets (ROA) | 18.13% |
| Return on Invested Capital (ROIC) | 20.68% |
| Return on Capital Employed (ROCE) | 28.34% |
| Revenue Per Employee | $3.09M |
| Profits Per Employee | $1.15M |
| Employee Count | 181 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 5.17 |
Taxes
In the past 12 months, CPRX has paid $63.30 million in taxes.
| Income Tax | 63.30M |
| Effective Tax Rate | 23.28% |
Stock Price Statistics
The stock price has decreased by -3.67% in the last 52 weeks. The beta is 0.79, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -3.67% |
| 50-Day Moving Average | 20.40 |
| 200-Day Moving Average | 22.09 |
| Relative Strength Index (RSI) | 52.92 |
| Average Volume (20 Days) | 1,118,169 |
Short Selling Information
The latest short interest is 8.42 million, so 6.88% of the outstanding shares have been sold short.
| Short Interest | 8.42M |
| Short Previous Month | 9.63M |
| Short % of Shares Out | 6.88% |
| Short % of Float | 7.34% |
| Short Ratio (days to cover) | 5.41 |
Income Statement
In the last 12 months, CPRX had revenue of $558.50 million and earned $208.67 million in profits. Earnings per share was $1.65.
| Revenue | 558.50M |
| Gross Profit | 463.73M |
| Operating Income | 243.42M |
| Pretax Income | 271.97M |
| Net Income | 208.67M |
| EBITDA | 281.25M |
| EBIT | 243.42M |
| Earnings Per Share (EPS) | $1.65 |
Balance Sheet
The company has $652.80 million in cash and $2.99 million in debt, giving a net cash position of $649.81 million or $5.31 per share.
| Cash & Cash Equivalents | 652.80M |
| Total Debt | 2.99M |
| Net Cash | 649.81M |
| Net Cash Per Share | $5.31 |
| Equity (Book Value) | 856.03M |
| Book Value Per Share | 6.99 |
| Working Capital | 645.73M |
Cash Flow
In the last 12 months, operating cash flow was $275.09 million and capital expenditures -$373,000, giving a free cash flow of $274.72 million.
| Operating Cash Flow | 275.09M |
| Capital Expenditures | -373,000 |
| Free Cash Flow | 274.72M |
| FCF Per Share | $2.24 |
Margins
Gross margin is 83.03%, with operating and profit margins of 43.58% and 37.36%.
| Gross Margin | 83.03% |
| Operating Margin | 43.58% |
| Pretax Margin | 48.70% |
| Profit Margin | 37.36% |
| EBITDA Margin | 50.36% |
| EBIT Margin | 43.58% |
| FCF Margin | 49.19% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.49% |
| Shareholder Yield | -6.49% |
| Earnings Yield | 8.13% |
| FCF Yield | 10.70% |
Analyst Forecast
The average price target for CPRX is $33.20, which is 58.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.20 |
| Price Target Difference | 58.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 11.36% |
| EPS Growth Forecast (5Y) | 26.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 16.12 and a Piotroski F-Score of 6.
| Altman Z-Score | 16.12 |
| Piotroski F-Score | 6 |